Navigation Links
Revolutionary statewide UC collaboration targets breast cancer
Date:9/29/2009

hey have, including health status, and other related lifestyle behaviors, such as diet, tobacco and drug use, environmental factors, gynecological history and family risk. This information will be used to help target prevention services now and in the future. Women diagnosed with breast cancer will additionally join a "survivorship cohort" comprised of women who have been diagnosed with breast cancer.

"We will be able to create a state-wide cohort of women at risk of breast cancer and develop the optimal methods for the early detection of all types of breast cancer," said Robert Hiatt, MD, PhD, professor and co-chair of the Department of Epidemiology and Biostatistics at UCSF. He is also director of population sciences and deputy director of the UCSF Helen Diller Family Comprehensive Cancer Center, and his research focuses on breast cancer and the environment. "The size and diversity of the survivorship cohort and the depth and quality of the information we'll have will be unprecedented and will enable the development and testing of robust new models of cancer outcomes and prognosis."

The UC system is particularly well-positioned for a project of ATHENA's magnitude because the medical centers annually screen as many as 80,000 women, and diagnose 2,500 patients with breast cancer. Still, said Esserman, the new project calls for "a re-imaginingand then a re-engineering so that we can continually improve what we do -- to improve our current processes, to streamline communication and access to information among care providers and patients, and to improve the efficiency of services."

The potential rewards are significant, she stressed. "This project will standardize the collection of structured data from both patients and physicians so that it is computable, interoperable, and reusable, and it will integrate molecular profiling at the time of diagnosis, and create an unparalleled biospecimen repository. The result will be a network that enab
'/>"/>

Contact: Elizabeth Fernandez
efernandez@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Revolutionary Drug Could Be New Hope for Adrenal Cancer Patients
2. Online Sign Making from Genuinesigns.com Just Got Faster, Easier, & Greener with its New Revolutionary System
3. St. Lukes Episcopal Hospital First in Houston to Offer Revolutionary Noninvasive Tumor Treatment
4. Norovirus Aboard Cruise Ship Marco Polo Rapidly Eradicated by Revolutionary new Vaporisation Process
5. National Breast Cancer Foundation, Inc to Partner with XtremeSportsID™ on Revolutionary Medical Identification Bracelet
6. Slimbolics Signs Marketing Contract for Its Revolutionary Weight Loss Aid
7. Obama White House Can Save $3.7 Trillion and Extend Lifespan 29+ Years, Predicts Revolutionary A4M Healthcare Plan
8. Dr. Chugay (drchugay.com) - Revolutionary Weight Loss Surgery
9. Symon Announces Revolutionary New Application InView Mobile™
10. New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test
11. Studies Highlight A Revolutionary New Method of Treating Post-Operative Bruising
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... , , , ... has announced the promotion of Mark Gastineau to senior vice ... Small Group, and Government Business Unit (ISGBU). Gastineau joined ... and Underwriting, leading the finance, underwriting and compliance areas in ...
... chronic cholestatic inflammatory liver disease characterized by diffuse fibrosing ... bile duct obliteration, biliary cirrhosis, and eventually hepatic failure. ... of presentation of PSC is mild to severe abdominal ... mechanisms responsible for the abdominal pain in PSC are ...
... recognized to result in fragile bones with increased risk ... has varied from 11% to 48%, with a fracture ... poorly understood. With liver transplantation becoming a viable option ... survival, bone disease is becoming the major determinant of ...
... with early-stage malignancy, study shows , MONDAY, Aug. 10 ... of a young woman with early-stage ovarian cancer can ... study has found. , Researchers at Columbia University ... during the first five years following the cancer diagnosis ...
... , MONDAY, Aug. 10 (HealthDay News) -- According to ... toddler with a snout and tail. , "Dogs basically ... said dog expert Stanley Coren, who was scheduled to ... Association annual meeting this week in Toronto. , The ...
... , NEW YORK, Aug. 10 Rx for ... to form ZiRx Therapeutics, Ltd., a joint venture that will utilize the ... drugs that potentially block or stop the spread of infectious diseases in ... antiviral drugs as well as drugs that are less susceptible to viral ...
Cached Medicine News:Health News:Mark Gastineau Named Senior Vice President of Individual, Small Group, and Government Business Unit at Blue Shield of California 2Health News:Gallbladder emptying in primary sclerosing cholangitis patients 2Health News:Fertility Can Be Preserved in Ovarian Cancer Patients 2Health News:Dogs and 2-Year-Olds on Same Mental Plane 2Health News:Dogs and 2-Year-Olds on Same Mental Plane 3Health News:Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd. 2Health News:Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd. 3
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, 2014 /PRNewswire/ ... biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ... need and commercial potential, today announced that it ... shares of its common stock and Series C ... stock.  Funds under the management of QVT Financial ...
(Date:12/24/2014)... 2014 Echo Therapeutics, Inc. (NASDAQ: ... on skin permeation, continuous glucose monitoring and associated ... has been appointed Chief Executive Officer effective ... 20 years of experience in the medical device, ... served as Vice President, Business Development, Otsuka Pharmaceuticals as ...
(Date:12/24/2014)... , December 24, 2014 ... Report on Global Disposable Syringe Industry of ... its online business intelligence library. ... Disposable Syringe Industry is a professional and ... market.  For overview analysis, the report introduces ...
Breaking Medicine Technology:Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... RenalGuard To Be PresentedFRANKLIN, Mass., May 15 ... company focused on innovative cardiac and vascular medical ... its RenalGuard System(TM) at EuroPCR, the annual meeting ... (EAPCI), May 19-22, 2009, in Barcelona, Spain. ...
... an Irreversible, Dual EGFR / HER2 Tyrosine Kinase Inhibitor, ... EGFR Activating Mutations - (1,2)-The First Presentation of Data ... Boehringer Ingelheim will present new data on the ... 1120 at the 2009 Annual Meeting of the American ...
Cached Medicine Technology:PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 2PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 3PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 4Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 2Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 3Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 4Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 5Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 6Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 7Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 8Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 9Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 10
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: